产品名称
氯霉素,大包装, British Pharmacopoeia (BP) Reference Standard
InChI key
WIIZWVCIJKGZOK-RKDXNWHRSA-N
InChI
1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1
SMILES string
OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+]([O-])=O
grade
pharmaceutical primary standard
API family
chloramphenicol
form
powder
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
mp
149-153 °C (lit.)
application(s)
pharmaceutical
pharmaceutical small molecule
format
neat
storage temp.
2-8°C
正在寻找类似产品? 访问 产品对比指南
Biochem/physiol Actions
作用机制:氯霉素通过与50S核糖体亚基结合并阻止氨酰基tRNA附着于核糖体来阻断肽基转移酶步骤,从而抑制细菌蛋白质的合成。 它还抑制线粒体和叶绿体蛋白的合成以及(p)ppGpp的核糖体形成,从而抑制rRNA的转录。
耐药性机制:使用氯霉素乙酰转移酶会使产物乙酰化并使其失活。
抗菌谱:这是一种针对革兰氏阳性和革兰氏阴性细菌的广谱抗生素,主要用于眼科和兽医目的。
耐药性机制:使用氯霉素乙酰转移酶会使产物乙酰化并使其失活。
抗菌谱:这是一种针对革兰氏阳性和革兰氏阴性细菌的广谱抗生素,主要用于眼科和兽医目的。
Application
Chloramphenicol BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.
Also used in monographs such as:Chloramphenicol Eye Drops Chloramphenicol Sodium Succinate Injection Chloramphenicol Capsules Chloramphenicol Ear Drops Chloramphenicol Eye Ointment
Also used in monographs such as:
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 500 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
signalword
Danger
hcodes
Hazard Classifications
Carc. 2 - Eye Dam. 1 - Repr. 2
存储类别
11 - Combustible Solids
wgk
WGK 3
法规信息
涉药品监管产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持
